Who We Are
A boutique executive search and advisory firm built for the biopharmaceutical sector — serving the full spectrum from emerging biotechs to established large pharma.
Built for Biopharma
Blake & Michaels is a boutique executive search and advisory firm serving the full spectrum of the biopharmaceutical sector — from emerging venture-backed biotechs and mid-sized development-stage companies to top-10 global pharma. We specialize in placing C-suite executives and functional heads at companies navigating critical inflection points. Operating as a high-touch alternative to global firms, we deliver sector depth, board fluency, and speed of execution.
Blake & Michaels maintains active relationships across clinical KOLs and physician-scientists, venture syndicate members, and board directors in oncology, rare and orphan disease, and other therapeutic areas. Whether our client is a Series A biotech structuring its first clinical team, a mid-sized company preparing for regulatory milestones, or an established large pharma requiring discreet leadership transition.
Venture-Backed Biotech
Series A through pre-IPO — first executive hires to crossover structuring.
Mid-Sized Biopharma
Development-stage and commercial-stage companies scaling clinical and functional leadership.
Large Pharma
Established organizations requiring discreet, high-urgency C-suite and functional head placement.
Founder & Principal
Founded and led by Jason Stewart, Blake & Michaels brings deep sector expertise, active network relationships, and a high-touch approach to every engagement.
Jason maintains active relationships across clinical KOLs and physician-scientists, venture syndicate members, and board directors.
With experience spanning Series A biotechs to top-10 global pharma, Jason brings the same rigor to a first executive hire as to a complex multi-role leadership buildout.
Therapeutic Areas & Modalities
Oncology
Solid tumors, hematologic malignancies, immuno-oncology, ADCs, and precision medicine platforms.
Rare & Orphan Disease
Gene therapy, enzyme replacement, RNA-targeted therapies, and small molecule approaches.
Neuroscience
CNS disorders, neurodegeneration, psychiatric conditions, and neurological rare diseases.
Immunology & Inflammation
Autoimmune, inflammatory, and fibrotic disease across biologics, small molecules, and next-generation therapies.
Cardiovascular & Metabolic
Cardiometabolic disease, heart failure, and lipid disorders — including CRISPR and RNA-based modalities.
Infectious Disease & Vaccines
Antiviral, antibacterial, and vaccine development across mRNA platforms, biologics, and small molecules.